Chad M. Thompson, Ph.D., MBA
SENIOR Health Scientist
| PHONE | 281-712-2062 x2002 |
|---|---|
| FAX | 832-218-2756 |
| cthompson@toxstrategies.com | |
| ADDRESS | 23501 Cinco Ranch Blvd Suite G265 Katy, TX 77494 |
Professional Profile
Dr. Chad M. Thompson is a senior health scientist with ToxStrategies based in Houston, Texas. He holds a doctorate degree in Biomedical Sciences from the University of Texas Health Science Center at Houston. Dr. Thompson’s graduate work focused on regulation and function of cytochrome P450-mediated drug metabolism. During his postdoctoral training, he investigated the potency and efficacy of various morphine and codeine congeners on opioid receptors. Subsequently, he served as a Risk Policy Fellow with the American Association for the Advancement of Science (AAAS) and the U.S. Environmental Protection Agency (EPA). Dr. Thompson then served as a Health Scientist at the U.S. EPA where he was involved with IRIS chemical risk assessments, the development of databases for physiological parameters suitable for application in physiologically-based pharmacokinetic (PBPK) modeling, as well as the development of risk assessment practices and policy documents. While at the U.S. EPA, his work also focused on susceptibility issues – including those related to genetics (e.g. polymorphisms), age (e.g. children), and health. He has also collaborated with national and international experts on issues regarding potential mechanisms of formaldehyde toxicity. Prior to serving as an AAAS Fellow, he also earned an MBA.
